No Data
No Data
Nevro (NYSE:NVRO) Has Debt But No Earnings; Should You Worry?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved
Med-tech and Healthcare Stocks With Upside During 2Q Earnings - Baird
Truist Financial Maintains Nevro(NVRO.US) With Hold Rating, Cuts Target Price to $10
Truist Financial analyst Richard Newitter maintains $Nevro(NVRO.US)$ with a hold rating, and adjusts the target price from $11 to $10.According to TipRanks data, the analyst has a success rate of 58.8
Nevro Price Target Cut to $10.00/Share From $11.00 by Truist Securities
Nevro Price Target Cut to $10.00/Share From $11.00 by Truist
Nevro Is Maintained at Hold by Truist Securities
Nevro Is Maintained at Hold by Truist
Express News | Nevro Corp : Truist Securities Cuts Target Price to $10 From $11